News

The majority of cases do not require the modification of therapy because it does not negatively affect the course of COVID-19.

The phase 3 data presented at the ISTH 2022 Annual Congress show an 86% reduction of treated bleeds in patients with hemophilia A or B with inhibitors.

Bronchiectasis varies in presentation and appears to affect individuals from broad areas of the country. According to Dr. Patrick Flume, the task is to figure out what the best method of management is.

Real-world patients showed improvement in visual acuity and anatomic parameters, but are still at an early time point in TRUCKEE study.

Evidence of pegcetacoplan treatment effect observed in the distribution of patients across quartiles in both OAKS and DERBY.

Monthly or every other month intravitreal pegcetacoplan reported to be tolerated in DERBY and OAKS trials.

The best overall outcomes were attained in eyes without fluid and ellipsoid zone integrity preservation, investigators said.

An assessment of anti-VEGF dose regimen strategies concludes with little difference in outcomes among treatment arms at 2 years.

New phase 3 data indicates significant improvements in disease severity in children 1-11 years old with eosinophilic esophagitis.

Previous literature indicated a higher prevalence of eczema in children who live in areas with hard water, but this association was not explored in adults until now.

The overall prevalence of NAFLD was 40.6%, with every NAFLD patient having a BMI of at least 25.

The topical therapy has been under investigation as a first-in-class therapy for this highly contagious skin condition.

A significant factor in treating sickle cell disease is the practice of shared decision-making, which gives the provider and patient a collaborative approach to disease management, according to Dr. Titilope Fasipe.

Buprenorphine has shown to be effective and has the potential for widespread use to address the opioid epidemic. A subset of individuals with OUD have been acquiring it without a prescription.

Dr. Karan Lal provides an overview of laser therapy for acne, and speaks on the "phenomenal" responses observed in patients with the first and only FDA approved laser treatment, AviClear.

Patients with obesity are at an increased risk of a number of diseases, including type 2 diabetes, IBD, and cardiovascular disease.

An Ohio State researcher discusses a new medical center education program for navigating addiction risk in pain patients.

New 21-month data from the SUSTAIN trial found that patients with no history of biologic therapies responded well to secukinumab.

Regular activity impairment did not differ much between the different countries, but there was a significant difference in informal care and productivity loss observed.

Early follow-up in patients with COPD led to lower rates of readmissions at 90 days, while patients with CHF saw lower 90-day mortality.

Nearly half of the study cohort did not fill a statin prescription within 90 days after an ASCVD event.

Dr. Raina describes the manifestations of pulmonary hypertension, CTEPH, and various treatment options available for the often underlooked condition.

Investigators suggest parents and clinicians should be mindful of children with suspected ACD with a history of exposure to jewelry, clothing, and belts with cobalt.

The majority of cases were mild to moderate in severity.

The Optimal screening ages for two measurements were 2 years and 6 years for the diagnosis of clinical type 1 diabetes.

Investigators suggest confronting sleep difficulties among patients with suicidal ideation through cognitive behavioral intervention could reduce effects of affective reactivity to interpersonal events.

Nonmetropolitan counties have a lower density of ophthalmologists compared to metropolitan counties.

The results are consistent with the original analysis from 2019, where the treatment resulted in a statistically significant effect on fibrosis improvement.